Ryder, Robert E J

• British Journal of Diabetes Vol. 20 No. 1 (2020): June 2020 - Editorials
  Diabetes medications with cardiovascular protection as we enter a new decade: can SGLT2 inhibitors, long-acting GLP-1 receptor agonists, pioglitazone and metformin complement each other to save lives?
  Abstract  PDF  HTML
• British Journal of Diabetes Vol. 21 No. 1 (2021): June 2021 - Original Research
  The United Kingdom’s first NHS EndoBarrier service for long-standing poorly controlled type 2 diabetes and obesity: outcomes one year after EndoBarrier removal
  Abstract  PDF  HTML
• British Journal of Diabetes Vol. 20 No. 1 (2020): June 2020 - Original Research
  Imeglimin, a novel, first in-class, blood glucose-lowering agent: a systematic review and meta-analysis of clinical evidence
  Abstract  PDF  Erratum  HTML
• British Journal of Diabetes Vol. 20 No. 1 (2020): June 2020 - Original Research
  The effect of dapagliflozin on alanine aminotransferase as a marker of liver inflammation: updated results from the ABCD dapagliflozin audit
  Abstract  PDF  HTML
• British Journal of Diabetes Vol. 20 No. 1 (2020): June 2020 - Original Research
  Early impact of liraglutide in routine clinical use (ABCD nationwide liraglutide audit) on cardiovascular risk (UKPDS risk engine)
  Abstract  PDF  HTML